Combination of tumor-associated surface protein antigens and tumorassociated sugars in the treatment and diagnosis of cancer

Details for Australian Patent Application No. 2003266278 (hide)

International Classifications

Event Publications

18 December 2003 Complete Application Filed

Priority application(s): A1216/2002 12.08.02 AT

22 April 2004 Application Open to Public Inspection

Published as AU-B-2003266278

12 November 2009 Application Accepted

Published as AU-B-2003266278

9 September 2010 Assignment before Grant

Igeneon Krebs-Immuntherapie Forschungsund Entwicklungs-AG The application has been assigned to Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH

16 September 2010 Standard Patent Sealed

15 September 2011 Assignment Registered

Meridian Biopharmaceuticals GmbH; Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; Greenovation Biotech GmbH The patent has been assigned to Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.